HRTX HERON THERAPEUTICS, INC. /DE/
Nasdaq · SEC CIK 818033 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 177 since 2021-07-15, latest 2026-08-10 10:18
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Cusack Thomas | Dir | — | — |
| Hensley Mark Earl | COO | — | — |
| Morgan Adam | Dir | — | — |
| Rosen David Efraim | 10% | — | — |
| Dissanaike Sharmila | Dir | — | — |
| Kaseta Michael | Dir | — | — |
| Christian Waage | Dir | — | — |
| Duarte Ira | EVP, CFO | — | — |
| Johnson Craig A | Dir | — | — |
| Collard Craig A | CEO, Dir | — | — |
Transactions 216
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-23 | 2021-09-21 | HRTX | Johnson Craig A | Dir | S - Sale | $12.30 | -250 | 3,090 | -7% | -$3,075 | |
| 2021-09-23 | 2021-09-21 | HRTX | Christian Waage | Dir | S - Sale | $12.31 | -300 | 3,500 | -8% | -$3,693 | |
| D | 2021-07-15 | 2021-07-13 | HRTX | MANHARD KIMBERLY | EVP, Drug Development, Dir | M - OptEx | — | +1,250 | 2,884 | +76% | — |
| D | 2021-07-15 | 2021-07-13 | HRTX | MANHARD KIMBERLY | EVP, Drug Development, Dir | F - Tax | $13.48 | -433 | 2,451 | -15% | -$5,837 |
| D | 2021-07-15 | 2021-04-30 | HRTX | Peraza Lisa | VP, CAO | J - Other | $13.90 | +1,530 | 13.5K | +13% | +$21.3K |
| D | 2021-07-15 | 2021-07-13 | HRTX | Peraza Lisa | VP, CAO | F - Tax | $13.48 | -191 | 13.8K | -1% | -$2,575 |
| D | 2021-07-15 | 2021-07-13 | HRTX | Peraza Lisa | VP, CAO | M - OptEx | — | +552 | 14.0K | +4% | — |
| D | 2021-07-15 | 2021-04-30 | HRTX | POYHONEN JOHN | Pres, CCO | J - Other | $13.90 | +971 | 21.4K | +5% | +$13.5K |
| D | 2021-07-15 | 2021-07-13 | HRTX | POYHONEN JOHN | Pres, CCO | M - OptEx | — | +1,250 | 22.6K | +6% | — |
| D | 2021-07-15 | 2021-07-13 | HRTX | POYHONEN JOHN | Pres, CCO | F - Tax | $13.48 | -433 | 22.2K | -2% | -$5,837 |
| D | 2021-07-15 | 2021-07-13 | HRTX | Quart Barry D | CEO, Dir | F - Tax | $13.48 | -963 | 99.4K | -1.0% | -$13.0K |
| D | 2021-07-15 | 2021-07-13 | HRTX | Quart Barry D | CEO, Dir | M - OptEx | — | +3,645 | 100.4K | +4% | — |
| D | 2021-07-15 | 2021-04-30 | HRTX | Quart Barry D | CEO, Dir | J - Other | $13.90 | +1,529 | 96.7K | +2% | +$21.3K |
| D | 2021-07-15 | 2021-07-13 | HRTX | Szekeres David Leslie | EVP, COO | M - OptEx | — | +1,250 | 3,597 | +53% | — |
| D | 2021-07-15 | 2021-07-13 | HRTX | Szekeres David Leslie | EVP, COO | F - Tax | $13.48 | -433 | 3,164 | -12% | -$5,837 |
| D | 2021-07-15 | 2021-04-30 | HRTX | Szekeres David Leslie | EVP, COO | J - Other | $13.90 | +1,530 | 2,347 | +187% | +$21.3K |
Purchase Sale Sale after option exercise All abbreviations